A partially hydrolyzed 100% whey formula and the risk of eczema and any allergy: an updated meta-analysis.

ABSTRACT:

Background

Recently, the role of using hydrolyzed formula for the prevention of allergic disease has been questioned. However, not all hydrolyzed formulas are equal. The efficacy of each hydrolyzed formula should be established separately. We updated evidence on the effectiveness of using partially hydrolyzed 100% whey formula (pHF), manufactured by a single manufacturer, for reducing the risk of eczema and allergy in healthy infants at high risk for allergy.

Methods

The Cochrane Library, MEDLINE, and EMBASE databases were searched in June 2016 for randomized and quasi-randomized controlled trials (RCTs); additional data were obtained from reviewed articles and the authors of included trials.

Results

Thirteen publications reporting on eight RCTs were included. Use of

SUBMITTER: Szajewska H 

PROVIDER: S-EPMC5527395 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature